Frontiers | Biomarkers for Heart Failure Prognosis: Proteins, Genetic Scores and Non-coding RNAs
Bedeutung der Herzinsuffizienzmarker BNP und NT-proBNP für die Klinik
Cyklus: KM2/19 – Kardiální markery
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues | SpringerLink
BNP und NT-proBNP: Zwei kardiale Marker werden „erwachsen“
NT-proBNP: The Gold Standard Biomarker in Heart Failure. | Semantic Scholar
Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers. - Abstract - Europe PMC
Biomarkers for the diagnosis and management of heart failure | SpringerLink
Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide | Biomarkers in Medicine
IJMS | Free Full-Text | BNP and NT-proBNP as Diagnostic Biomarkers for Cardiac Dysfunction in Both Clinical and Forensic Medicine
OLM (cs) K 1.7. budou převedeny kardiální markery
Kardiomarkery (učební text): Srdeční selhání
Kardiomarkery (učební text)
KARDIOMARKERY (Kardiální markery) Ukazatelé poškození myokardu - ppt stáhnout
Biomarkers for the diagnosis and management of heart failure | SpringerLink
PPT - KARDIOMARKERY ( Kardiální markery ) Ukazatelé poškození myokardu PowerPoint Presentation - ID:4396392
Kardiální markery
Cardiac Complications during Oncologic Treatment - Current Diagnostic Methods
Cardiac Markers-cTnI/cTnT/ NT-proBNP/MYO/D-Dimer | Fapon Biotech Inc.
Established and Emerging Roles of Biomarkers in Heart Failure | Circulation Research
Troponiny - ManaCon
Untitled
Biomarkers in Advanced Heart Failure | Circulation: Heart Failure
